Abstract
Purpose
Assessing the percutaneous absorption of cosmetic ingredients using in-vitro human skin reveals certain limitations, such as restricted anatomical sites and repeated exposure, and to overcome these issues, in-vivo studies are required. The aim of the study is to develop a robust non-invasive in-vivo protocol that should be applicable to a wide range of application.
Methods
A robust tape stripping protocol was therefore designed according to recent recommendations, and the impact of two different washing procedures on caffeine distribution in tape strips was investigated to optimise the protocol. The optimised protocol was then used to study the effect of age and anatomical area on the percutaneous absorption of caffeine, including facial areas which are not readily available for in-vitro studies.
Results
With tape stripping, a difference between the percutaneous absorption on the face (forehead, cheek) and the volar forearm was observed. No obvious difference was observed between percutaneous absorption in young and post-menopausal women, but this could be due to the limited number of subjects.
Conclusion
This tape stripping protocol is now to be deployed to address many other factors, such as percutaneous absorption in other anatomical areas (e.g. abdomen, axilla, etc.), impact of repeated applications and effect of formulation.
Similar content being viewed by others
References
OECD. OECD Guideline for the testing of chemicals, N° 428. Skin Absorption: In vitro Method. In. Paris, France; 2004. p. 8.
Law RM, Ngo MA, Maibach HI. Twenty Clinically Pertinent Factors/Observations for Percutaneous Absorption in Humans. Am J Clin Dermatol. 2020;21(1):85–95.
Bormann JL, Maibach HI. Effects of anatomical location on in vivo percutaneous penetration in man. Cutan Ocul Toxicol. 2020;39(3):213–22.
Roskos KV, Maibach HI, Guy RH. The effect of aging on percutaneous absorption in man. J Pharmacokinet Biopharm. 1989;17(6):617–30.
Rougier A, Lotte C, Corcuff P, Maibach HI. Relationship between skin permeability and corneocyte size according to anatomic site, age and sex in man. J Soc Cosmet Chem. 1988;39:15–26.
Hayashi T, Kawaguchi H, Eifuku T, Matsuoka H, Kawabata A, Nagai N. Changes in percutaneous absorption of fentanyl patches in rats treated with a sebum-like secretion. Chem Pharm Bull. 2020;68(9):879–84.
Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U. Penetration Profile of Microspheres in Follicular Targeting of Terminal Hair Follicles. J Investig Dermatol. 2003;123(1):168–76.
Swales JG, Hamm G, Clench MR, Goodwin RJA. Mass spectrometry imaging and its application in pharmaceutical research and development: A concise review. Int J Mass Spectrom. 2019;437:99–112.
Erdo F, Hashimoto N, Karvaly G, Nakamichi N, Kato Y. Critical evaluation and methodological positioning of the transdermal microdialysis technique. A review Journal of Controlled Release. 2016;233:147–61.
Benfeldt E, Hansen SH, Volund A, Menne T, Shah VP. Bioequivalence of Topical Formulations in Humans: Evaluation by Dermal Microdialysis Sampling and the Dermatopharmacokinetic Method. J Invest Dermatol. 2006;127(1):170–8.
Pena A-M, Chen X, Pence IJ, Bornschlögl T, Jeong S, Grégoire S, Luengo GS, Hallegot P, Obeidy P, Feizpour A, Chan KF, Evans CL. Imaging and quantifying drug delivery in skin – Part 2: Fluorescence andvibrational spectroscopic imaging methods. Adv Drug Deliv Rev. 2020;153:147–68.
Sarri B, Chen X, Canonge R, Grégoire S, Formanek F, Galey JB, Potter A, Bornschlögl T, Rigneault H. In vivo quantitative molecular absorption of glycerol in human skin using coherent anti-Stokes Raman scattering (CARS) and two-photon auto-fluorescence. J Control Release. 2019;308:190–6.
Shah VP, Flynn G, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL. Bioequivalence of Topical Dermatological Dosage Forms-Methods of Evaluation of Bioequivalence. Pharm Res. 1998;15(2):167–71.
Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm. 2008;68(3):453–66.
N’Dri-stempfer B, Navidi WC, Guy RH, Bunge AL. Improved Bioequivalence Assessment of Topical Dermatological Drug Products Using Dermatopharmacokinetics. Pharm Res. 2009;26(2):316–28.
Lademann J, Jacobi U, Surber C, Weigmann HJ, Fluhr JW. The tape stripping procedure – evaluation of some critical parameters. Eur J Pharm Biopharm. 2009;72(2):317–23.
Lademann J, Meinke MC, Schanzer S, Richter H, Darvin ME, Haag SF, Fluhr JW, Weigmann H-J, Sterry W, Patzelt A. In vivo methods for the analysis of the penetration of topically applied substances in and through the skin barrier. Int J Cosmet Sci. 2012;34(6):551–9.
Reddy MB, Stinchcomb AL, Guy RH, Bunge AL. Determining Dermal Absorption Parameters in Vivo From Tape Strip Data. Pharm Res. 2002;19(3):292–8.
Chirikhina E, Chirikhin A, Xiao P, Dewsbury-Ennis S, Bianconi F. In vivo assessment of water content, trans-epidermialwater loss and thickness in human facial skin. Applied Sciences (Switzerland). 2020;10(17):6139.
Rothe H, Obringer C, Manwaring J, Avci C, Wargniez W, Eilstein J, Hewitt N, Cubberley R, Duplan H, Lange D, Jacques-Jamin C, Klaric M, Schepky A, Gregoire S, Gregoire S. Comparison of protocols measuring diffusion and partition coefficients in the stratum corneum. J Appl Toxicol. 2017;37(7):808–16.
Leal LB, Cordery SF, gado-Charro MBa, Bunge AL, Guy RH. Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug. Pharmaceutical Research. 2017:1–8.
Schäfer-Korting M, Mahmoud A, Lombardi Borgia S, Brüggener B, Kleuser B, Schreiber S, Mehnert W. Reconstructed Epidermis and Full-Thickness Skin for Absorption Testing: Influence of the Vehicles used on Steroid Permeation. ATLA. 2008;36(4):441–52.
Pershing LK, Bakhtian S, Poncelet CE, Corlett JL, Shah VP. Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources. J Pharm Sci. 2002;91(5):1312–23.
Kalia YN, Pirot F, Guy RH. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo. Biophys J. 1996;71(5):2692–700.
Russell LM, Wiedersberg S, Delgado-Charro BM. The determination of stratum corneum thickness An alternative approach. Eur J Pharm Biopharm. 2008;69(3):861–70.
Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. Effect of propylene glycol on ibuprofen absorption into human skin in vivo. J Pharm Sci. 2008;97(1):185–97.
Egawa M, Hirao T, Takahashi M. In vivo estimation of stratum corneum thickness from water concentration profiles obtained with raman spectroscopy. Acta Dermato-Venereologica. 2007;87(1):4-
Shah VP. Progress in methodologies for evaluating bioequivalence of topical formulations. Am J Clin Dermatol. 2001;2(5):275–80.
Wargniez W, Jungman E, Wilkinson S, Seyler N, Gr+®goire S. Inter-laboratory skin distribution study of 4-n-butyl resorcinol: The importance of liquid chromatography/mass spectrometry (HPLCGÇôMS/MS) bioanalytical validation. Journal of Chromatography B. 2017;1060(Supplement C):416–423.
Wiedersberg S, Naik A, Leopold CS, Guy RH. Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability. Br J Dermatol. 2009;160(3):676–86.
Zhang Y, Kung C-P, Iliopoulos F, Sil BC, Hadgraft J, Lane ME. Dermal Delivery of Niacinamide—In Vivo Studies. Pharmaceutics. 2021;13(5):726.
Wester RC, Maibach HI. Regional variation in percutaneous absorption: Principles and application to human risk assessment. In: Bronaugh RL, Maibach HI, editors. Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology. 4th ed. New York: Marcel Dekker, Inc.; 2005. p. 85–93.
Hoppel M, Tabosa MAM, Bunge AL, Delgado-Charro MB, Guy RH. Assessment of Drug Delivery Kinetics to Epidermal Targets In Vivo. AAPS J. 2021;23(3):49.
Cua AB, Wilhelm KP, Maibach HI. Skin Surface Lipid and Skin Friction: Relation to Age, Sex and Anatomical Region. Skin Pharmacology and Physiology. 1995;8(5):246–51.
ACKNOWLEDGMENTS AND DISCLOSURES
We thank the Centre de Recherche Biologique, Hopital Saint-Louis, Paris for conducting study A, and Intertek Etudes Cliniques for conducting studies B and C. We also wish to thank Acolad and Conor McMahon for language revisions. The authors are full-time employees of L'Oréal.
Author information
Authors and Affiliations
Contributions
WW: Investigation, writing original draft; SC: Investigation clinical studies B and C, writing original draft; NB: Conceptualisation, investigation clinical study A, writing and review; OD: Formal analysis, writing and review; SN: Conceptualisation, writing and review; SG: Conceptualisation, writing original draft and editing.
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wargniez, W., Connétable, S., Bourokba, N. et al. In-Vivo Tape Stripping Study with Caffeine for Comparisons on Body Sites, Age and Washing. Pharm Res 39, 1935–1944 (2022). https://doi.org/10.1007/s11095-022-03311-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-022-03311-0